Interestingly, in a randomised placebo-controlled study involving overweight women suffering from PCOS, circulating levels of resistin were significantly decreased by the insulin-sensitising agent rosiglitazone [206]. The gene discussed is INS; the disease is polycystic ovary syndrome.